See more : Pond Technologies Holdings Inc. (PNDHF) Income Statement Analysis – Financial Results
Complete financial analysis of IMAC Holdings, Inc. (IMAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IMAC Holdings, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Cirrus Networks Holdings Limited (CNW.AX) Income Statement Analysis – Financial Results
- S.J.S. Enterprises Limited (SJS.NS) Income Statement Analysis – Financial Results
- Ample Electronic Technology Co.,Ltd. (4760.TWO) Income Statement Analysis – Financial Results
- Changzhou Langbo Sealing Technologies Co.,Ltd. (603655.SS) Income Statement Analysis – Financial Results
- Invesco Mortgage Capital Inc. (0JD3.L) Income Statement Analysis – Financial Results
IMAC Holdings, Inc. (IMAC)
About IMAC Holdings, Inc.
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.20M | 16.19M | 14.39M | 12.84M | 15.13M | 6.70M | 786.03K | 15.00K |
| Cost of Revenue | 1.35M | 1.51M | 1.63M | 1.62M | 2.54M | 933.91K | 63.22K | 4.27K |
| Gross Profit | 3.85M | 14.68M | 12.76M | 11.21M | 12.59M | 5.77M | 722.81K | 10.73K |
| Gross Profit Ratio | 74.05% | 90.68% | 88.68% | 87.35% | 83.21% | 86.06% | 91.96% | 71.56% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.46M | 21.80M | 19.73M | 15.44M | 15.98M | 7.81M | 1.45M | 204.78K |
| Selling & Marketing | 7.73K | 1.10M | 1.32M | 933.34K | 1.24M | 859.19K | 119.87K | 25.00K |
| SG&A | 1.47M | 22.90M | 21.06M | 16.38M | 17.22M | 8.67M | 1.57M | 229.78K |
| Other Expenses | 3.56M | 1.63M | 1.65M | 1.31M | 1.55M | 18.36K | 65.90K | 0.00 |
| Operating Expenses | 5.03M | 24.53M | 22.71M | 17.68M | 18.77M | 9.32M | 1.64M | 229.78K |
| Cost & Expenses | 6.38M | 26.03M | 24.33M | 19.31M | 21.31M | 10.25M | 1.70M | 234.05K |
| Interest Income | 0.00 | 10.58K | 2.89K | 6.07K | 7.79K | 7.54K | 14.82K | 4.00 |
| Interest Expense | 0.00 | 14.19K | 504.10K | 563.07K | 897.69K | 153.82K | 27.15K | 4.00 |
| Depreciation & Amortization | 403.59K | 1.63M | 1.65M | 1.72M | 1.55M | 651.07K | 65.90K | 219.05K |
| EBITDA | -5.95M | -10.20M | -8.39M | -3.26M | -4.50M | -2.98M | -823.48K | -397.44K |
| EBITDA Ratio | -114.43% | -50.91% | -57.28% | -36.96% | -30.68% | -44.47% | -104.42% | -2,649.60% |
| Operating Income | -6.38M | -9.85M | -9.95M | -6.47M | -6.19M | -3.55M | -915.07K | -219.05K |
| Operating Income Ratio | -122.68% | -60.85% | -69.16% | -50.43% | -40.89% | -53.00% | -116.42% | -1,460.31% |
| Total Other Income/Expenses | -99.85K | 6.11K | -443.89K | 993.86K | -765.96K | -233.48K | -1.47K | -178.39K |
| Income Before Tax | -6.48M | -18.31M | -10.54M | -5.54M | -6.95M | -3.78M | -916.53K | -397.44K |
| Income Before Tax Ratio | -124.60% | -113.14% | -73.28% | -43.18% | -45.96% | -56.48% | -116.60% | -2,649.60% |
| Income Tax Expense | 0.00 | 8.43M | 561.43K | 24.37K | 427.20K | -79.65K | -818.59K | -16.65K |
| Net Income | -9.42M | -26.74M | -11.10M | -5.57M | -7.38M | -3.05M | -57.18K | -380.80K |
| Net Income Ratio | -181.23% | -165.24% | -77.18% | -43.37% | -48.78% | -45.57% | -7.27% | -2,538.65% |
| EPS | -5.06 | -28.38 | -14.77 | -15.11 | -28.55 | -12.65 | -0.38 | -2.56 |
| EPS Diluted | -7.36 | -28.38 | -14.77 | -15.11 | -28.55 | -12.65 | -0.38 | -2.56 |
| Weighted Avg Shares Out | 1.62M | 942.46K | 751.72K | 368.34K | 258.45K | 241.43K | 150.40K | 149.02K |
| Weighted Avg Shares Out (Dil) | 1.11M | 942.46K | 751.72K | 368.34K | 258.45K | 241.43K | 150.40K | 149.02K |
Which states have done the least to contain coronavirus?
Coronavirus: How COVID-19 isolation works and what the rules are
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 2.39%
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 11.37%
A test of our national character with little to guide us, except that darned epidemic curve
Blues beat Rangers 3-1 for 8th straight victory
David Beckham hopes MLS can challenge European leagues in next 10 years
Morrison on track to murder elderly for budget - MacroBusiness
Chess: Alireza Firouzja wins first major title at age of 16
El no va más en edificios
Source: https://incomestatements.info
Category: Stock Reports